Using a new approach, scientists at The Scripps Research Institute (TSRI) and collaborating institutions have discovered a novel drug candidate that could be used to treat certain types of breast cancer, lung cancer and melanoma.
Mar 7, 2016
0
182
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University ...
Nov 25, 2015
0
115
Gastric cancer, otherwise known as stomach cancer, does not respond well to existing treatments and it is currently the third leading cause of cancer death in the world (after lung and liver cancer). Researchers have discovered ...
Oct 29, 2015
0
135
A drug candidate that overstimulates proteins crucial for tumor growth shows promise as a new strategy to treat a wide range of cancers. The demands of rapid cell division put a strain on cancer cells, and the approach works ...
Aug 10, 2015
0
289
Researchers have packaged a widely used cancer drug into nanoparticles, more than doubling its effectiveness at destroying tumors.
Aug 4, 2015
0
72
More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best.
Apr 22, 2015
0
97
An experimental drug rapidly shrinks most tumors in a mouse model of human breast cancer, researchers report in the Proceedings of the National Academy of Sciences. When mice were treated with the experimental drug, BHPI, ...
Mar 30, 2015
0
118
One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device ...
Mar 16, 2015
0
224
A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.
Feb 26, 2015
0
24
Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 (HSP90) also enables estrogen receptor-positive (ER+) ...
Dec 8, 2014
0
0
